FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare

SPOTLIGHT: Stada to buy Forum BioScience


German generics maker Stada is plunking down 56 million euro ($76.6 million) for the U.K. pharma group Forum Bioscience. Antitrust regulators will have to bless the deal. Report

More stories about Generics  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

What is 3 + 22?
To combat spam, please solve the math question above.